Old Web
English
Sign In
Acemap
>
authorDetail
>
Jorge David Rojas Márquez
Jorge David Rojas Márquez
National University of Cordoba
Biology
Immunology
PI3K/AKT/mTOR pathway
Trypanosoma cruzi
Microbiology
4
Papers
33
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Listeria exploits IFITM3 to suppress antibacterial activity in phagocytes.
2021
Nature Communications
Joel M. J. Tan
Monica E Garner
James M. Regeimbal
Catherine J. Greene
Jorge David Rojas Márquez
Dustin A. Ammendolia
Adam R.R. McCluggage
Taoyingnan Li
Katherine J. Wu
Marija Cemma
Philip P. Ostrowski
Brian Raught
Michael S. Diamond
Sergio Grinstein
Robin M. Yates
Darren E. Higgins
John H. Brumell
Show All
Source
Cite
Save
Citations (0)
Cutting Edge: NOX2 NADPH Oxidase Controls Infection by an Intracellular Bacterial Pathogen through Limiting the Type 1 IFN Response.
2020
Journal of Immunology
Jorge David Rojas Márquez
Taoyingnan Li
Adam R.R. McCluggage
Joel M. J. Tan
Aleixo M. Muise
Darren E. Higgins
John H. Brumell
Show All
Source
Cite
Save
Citations (3)
Mammalian Target of Rapamycin Inhibition in Trypanosoma cruzi-Infected Macrophages Leads to an Intracellular Profile That Is Detrimental for Infection
2018
Frontiers in Immunology
Jorge David Rojas Márquez
Yamile Ana
Ruth Eliana Baigorrí
Cinthia C. Stempin
Fabio M. Cerbán
Show All
Source
Cite
Save
Citations (13)
GRAIL and Otubain-1 are Related to T Cell Hyporesponsiveness during Trypanosoma cruzi Infection.
2017
PLOS Neglected Tropical Diseases
Cinthia C. Stempin
Jorge David Rojas Márquez
Yamile Ana
Fabio M. Cerbán
Show All
Source
Cite
Save
Citations (17)
1